s6y

SL Science Holding Ltd

Ticker
SLBT
CIK
2070534
Industry
Biological Products, (No Diagnostic Substances)

Ownership 13

  1. 3 Initial statement of beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities
  8. 3 Initial statement of beneficial ownership of securities
  9. 3 Initial statement of beneficial ownership of securities
  10. 3 Initial statement of beneficial ownership of securities

All 13 ownership filings

Prospectus 15

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  3. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  4. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  5. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  6. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  7. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  8. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  9. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  10. DRSLTR Correspondence Related to Draft Registration Statement

All 15 prospectus filings

Other 22

  1. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. SCHEDULE 13D/A
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. EFFECT Notice of Effectiveness
  8. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  9. UPLOAD Letter (PDF)
  10. F-1 Registration statement for securities of certain foreign private issuers

All 22 other filings